학술논문

One year results of a phase 1 study of the safety and tolerability of combination therapy using sustained release intravitreal triamcinolone acetonide and ranibizumab for subfoveal neovascular AMD
Document Type
Report
Source
British Journal of Ophthalmology. May, 2015, Vol. 99 Issue 5, p618, 6 p.
Subject
Macular degeneration -- Risk factors
Macular degeneration -- Care and treatment
Triamcinolone -- Dosage and administration
Drug therapy, Combination -- Usage
Health
Language
English
ISSN
0007-1161